These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 4999204
1. Combined intramuscular administration of depot fluphenazine and benztropinemesylate in chronic schizophrenic patients. Bucci L. Curr Ther Res Clin Exp; 1971 Aug; 13(8):545-8. PubMed ID: 4999204 [No Abstract] [Full Text] [Related]
2. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders. Timberlake WH. Neurology; 1970 Dec; 20(12):Suppl:31-5. PubMed ID: 4921586 [No Abstract] [Full Text] [Related]
3. [Preliminary tests with injectable biperiden in the treatment of neurodysleptic crises induced by neuroleptic drugs]. Madalena JC. Hospital (Rio J); 1969 Aug; 76(2):497-500. PubMed ID: 5307639 [No Abstract] [Full Text] [Related]
8. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics. Klett CJ, Caffey E. Arch Gen Psychiatry; 1972 Apr; 26(4):374-9. PubMed ID: 4552131 [No Abstract] [Full Text] [Related]
10. The schizophrenic. The pill or not the pill--fluphenazine enanthate an answer. Brauer WW. Minn Med; 1972 Nov; 55(11):1058-60. PubMed ID: 4669975 [No Abstract] [Full Text] [Related]
11. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders. Timberlake WH. Neurology; 1970 Dec; 20(12):31-5. PubMed ID: 4924342 [No Abstract] [Full Text] [Related]
12. Treatment of resistant schizophrenics with extreme high dosage fluphenazine hydrochloride. Itil T, Keskiner A, Heinemann L, Han T, Gannon P, Hsu W. Psychosomatics; 1970 Dec; 11(5):456-63. PubMed ID: 4919176 [No Abstract] [Full Text] [Related]
13. Intramuscular long-acting fluphenazine in the treatment of schizophrenia. Malm U. Acta Psychiatr Scand; 1970 Dec; 46(3):225-37. PubMed ID: 5490589 [No Abstract] [Full Text] [Related]
14. A clinical evaluation of fluphenazine enanthate. Goldberg HL, DiMascio A, Chaudhary B. Dis Nerv Syst; 1970 Sep; 31():Suppl:46-7. PubMed ID: 5476358 [No Abstract] [Full Text] [Related]
15. Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine. Adamson L, Curry SH, Bridges PK, Firestone AF, Lavin NI, Lewis DM, Watson RD, Xavier CM, Anderson JA. Dis Nerv Syst; 1973 Sep; 34(4):181-91. PubMed ID: 4711886 [No Abstract] [Full Text] [Related]
16. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study. Levine J, Schooler NR, Severe J, Escobar J, Gelenberg A, Mandel M, Sovner R, Steinbook R. Adv Biochem Psychopharmacol; 1980 Sep; 24():483-93. PubMed ID: 6996445 [No Abstract] [Full Text] [Related]
18. Fluphenazine hydrochloride, enanthate, and decanoate in the management of chronic psychosis. Itil T, Keskiner A. Dis Nerv Syst; 1970 Sep; 31():Suppl:37-42. PubMed ID: 4920313 [No Abstract] [Full Text] [Related]
19. [Contribution to the infusion therapy with fluphenazine in schizophrenics with regard to the control of the neuroleptic threshold]. Dengler K. Med Welt; 1969 Apr 19; 16():977-81. PubMed ID: 5784368 [No Abstract] [Full Text] [Related]
20. Hospital experience with fluphenazine enanthate. Young E. Dis Nerv Syst; 1970 Oct 19; 31(10):705-9. PubMed ID: 5482921 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]